Navigation Links
Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
Date:1/29/2008

Athletes Using Surgex(TM) can be Assured of No Banned Substances

BASKING RIDGE, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), announced today that Surgex(TM) (http://www.surgexsports.com) has been tested and certified into the Banned Substance Control Group's (BSCG) certification program. This is the only certification program in the US that uses a World Anti Doping Agency accredited laboratory to detect for dangerous banned substances in nutritional supplements. Each batch of Millennium's line of Surgex(TM) products are now tested and certified not to contain substances such as hormones, steroids, stimulants, diuretics, etc that are banned for Professional, Collegiate and Olympic sports. The BSCG certification in addition to the Surgex'(TM) clinical trials should provide the product a competitive advantage upon commercialization into the billion dollar sports nutritional supplement marketplace.

"The athlete can now be assured that our Surgex(TM) line of products can be safely consumed as each batch is tested for a list of substances that are banned by organizations such as the International Olympic Committee (IOC), the World Anti-Doping Agency (WADA), the United States Anti-Doping Agency (USADA), the National Collegiate Athletic Association (NCAA), the National Football League (NFL), and many other professional and amateur sports leagues." states Carl Germano, RD, CNS, CDN, clinical nutritionist and VP of Research & product Development for Millennium Biotechnologies.

With over 5 years in the medical market as a nutritional adjunct to medical care for immuno-compromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Surgex(TM) line of products is breaking new ground for credibility and pro
'/>"/>

SOURCE Millennium Biotechnologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
2. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
3. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
4. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
8. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer for ... As a result of the waiver, the transaction is ... the tender offer on January 24, 2014 following the currently scheduled ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... 26 Reportlinker.com announces that a new market ... Reportlinker Adds Medical Devices & Equipment ... http://www.reportlinker.com/p0156603/Reportlinker-Adds-Medical-Devices--Equipment-in-India-(2009).html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... new lifestyles has made healthcare services in India ...
... The American College of ... Annual Scientific Meeting, becoming the first medical association to expand into ... Meeting attendees, authors and presenters can, for the first time, not ... clinical gastroenterology during -- and well after -- the San Diego ...
Cached Medicine Technology:Reportlinker Adds Medical Devices & Equipment in India (2009) 2Reportlinker Adds Medical Devices & Equipment in India (2009) 3Reportlinker Adds Medical Devices & Equipment in India (2009) 4Reportlinker Adds Medical Devices & Equipment in India (2009) 5Reportlinker Adds Medical Devices & Equipment in India (2009) 6American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 2American College of Gastroenterology to Revolutionize Scientific Exchange on Within3 3
(Date:4/17/2014)... less than 40 years away from a food shortage ... according to a top scientist at the U.S. Agency ... history, food production will be limited on a global ... said Dr. Fred Davies, senior science advisor for the ... as politically destabilizing by 2050 as energy issues are ...
(Date:4/17/2014)... its status as the leading weapon against the deadly ... with new research indicating it simply needs to be ... of the cheap anti-malarial drug chloroquine in treating and ... more than half a million people each year around ... developed resistance to chloroquine, but research carried out at ...
(Date:4/16/2014)... (April 16, 2014) A team that includes scientists from ... Science Center at San Antonio, Johns Hopkins University and St. ... a common fungus to infect the body. , The fungal ... and oral thrush, and is the most common fungal pathogen ...
(Date:4/15/2014)... mystery and in the process have found a potentially less ... million people a year. The researchers say they now understand the ... in use for more than 50 years even though it ... the microbes it attacks. , A report of the ...
(Date:4/14/2014)... at Henry Ford Hospital reached a medical milestone April ... a novel way to access the heart. , Henry ... performing the unique procedure called transcaval valve replacement, which ... , Northern Michigan resident Viola Waller, 80, underwent Henry ...
Breaking Medicine News(10 mins):Health News:Food shortages could be most critical world issue by mid-century 2Health News:Scientists find new way to fight malaria drug resistance 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Henry Ford Hospital hits new heart valve surgery milestone 2
... to the World Health,Organization, more than five million ... Glaucoma-Blindness ("White-Canes").,Most lacked the opportunity to get tested ... sight. Dr. Robert Welsh, a Rotarian, a,world-renowned Eye ... 80,000 new cases a year through administering his ...
... Webcast on February 21st at 12:00 p.m. Pacific Time ... (Amex: SYI ) announced today that Noah Berkowitz, ... present at,the Roth 20th Annual OC Growth Stock Conference ... (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel in ...
... time has come for breast cancer risk assessment, counseling ... the realm of primary care, according to a presentation ... Boston. , "A growing body of evidence has documented ... those with mutations in the BRCA1 and BRCA2 genes," ...
... a race to achieve accountability and credibility, the mental ... psychotherapeutic procedures that have been shown in empirical ... , The problem with EBTs, however, is that ... like reductions in symptoms, more harmonious relationships, or improved ...
... , , A 40,000-year-old tooth has provided scientists with ... to place during their lifetimes. In a collaborative project ... Greece, Professor Michael Richards of the Max Planck institute ... UK, and his team used laser technology to collect ...
... Dividend, ABBOTT PARK, Ill., Feb. 15 The ... increased the company,s quarterly,common dividend 10.8 percent to 36 ... year that Abbott has increased its,dividend payout and the ... 1924. The cash dividend is payable May 15, 2008, ...
Cached Medicine News:Health News:Dr. Welsh 'Self-Test' Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:Personalized medicine can cut breast cancer risk 2Health News:Mobile Neanderthals 2
The Benchmark Microplate Reader, with its increased wavelength range of 340 to 750 nm and high performance optics, provides flexibility for specialized applications requiring increased linearity, ult...
Plate Reader is an eight channel photometer for the sequential and simultaneous reading of micro-plate strips with 96 wells. High technology, user friendly, powerful and reliable....
TC-98 elisa strip reader. Reads, calculates, and prints results for up to 12 wells in about 30 seconds. Single point calibration. Multi-point calibration....
Stat Fax 2200 Incubator shaker....
Medicine Products: